BIOMERICA INC (BMRA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 7M 14M 21M FY11: 4.9M FY12: 6.1M FY13: 6.5M FY14: 5.1M FY15: 5M FY16: 5.1M FY17: 5.8M FY18: 5.6M FY19: 5.2M FY20: 6.7M FY21: 7.2M FY22: 18.9M FY23: 5.3M FY24: 5.4M FY25: 5.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 1.5M 3M 4.5M FY11: 1.5M FY12: 2.3M FY13: 2.4M FY14: 1.7M FY15: 1.5M FY16: 1.5M FY17: 2M FY18: 1.8M FY19: 1.3M FY20: 1.7M FY21: 366.3K FY22: 3M FY23: 446K FY24: 611K FY25: 498K FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-9M -6M -3M 0 3M 6M 9M FY11: -132.3K FY12: 505K FY13: 514K FY14: -446.6K FY15: -670.6K FY16: -827K FY17: -954.6K FY18: -1.5M FY19: -2.4M FY20: -2.7M FY21: -7.5M FY22: -4.5M FY23: -7.2M FY24: -6.4M FY25: -5.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-9M -6M -3M 0 3M 6M 9M FY11: 157.4K FY12: 548.4K FY13: 537K FY14: -215.7K FY15: -331.4K FY16: -1.5M FY17: -908.6K FY18: -1.5M FY19: -2.4M FY20: -2.7M FY21: -7.4M FY22: -4.5M FY23: -7.1M FY24: -6M FY25: -5M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 6M 12M 18M FY11: 3.4M FY12: 3.8M FY13: 4M FY14: 3.5M FY15: 3.4M FY16: 3.6M FY17: 3.8M FY18: 3.8M FY19: 3.9M FY20: 5M FY21: 6.8M FY22: 15.9M FY23: 4.9M FY24: 4.8M FY25: 4.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-6M -4M -2M 0 2M 4M 6M FY11: 328.8K FY12: 147.4K FY13: 1.4M FY14: -862.3K FY15: -405.5K FY16: -208.8K FY17: -722.9K FY18: -1.2M FY19: -2.2M FY20: -4.3M FY21: -5.3M FY22: -479K FY23: -5.5M FY24: -5.4M FY25: -3.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-6M -4M -2M 0 2M 4M 6M FY11: 187.7K FY12: -17.4K FY13: 1.1M FY14: -999.5K FY15: -416K FY16: -300.3K FY17: -818.9K FY18: -1.3M FY19: -2.3M FY20: -4.3M FY21: -5.4M FY22: -536K FY23: -5.5M FY24: -5.4M FY12 FY14 FY16 FY18 FY20 FY22 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 5M 10M 15M FY11: 6.7M FY12: 7.1M FY13: 7.5M FY14: 7.4M FY15: 7.6M FY16: 7.6M FY17: 8.3M FY18: 8.6M FY19: 9.2M FY20: 10.2M FY21: 11.9M FY22: 12.7M FY23: 14.2M FY24: 2.1M FY25: 2.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '11: 0.02 Q1 '12: 0.04 Q2 '12: 0.07 Q3 '12: 0.09 Q4 '12: 0.09 Q1 '13: 0.11 Q2 '13: 0.11 Q3 '13: 0.07 Q4 '13: 0.06 Q1 '14: -0.00 Q2 '14: -0.06 Q3 '14: -0.05 Q4 '14: -0.03 Q1 '15: -0.04 Q2 '15: -0.04 Q3 '15: -0.06 Q4 '15: -0.04 Q1 '16: -0.02 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: -0.20 Q1 '17: -0.20 Q2 '17: -0.21 Q3 '17: -0.23 Q4 '17: -0.11 Q1 '18: -0.12 Q2 '18: -0.13 Q3 '18: -0.13 Q4 '18: -0.17 Q1 '19: -0.20 Q2 '19: -0.22 Q3 '19: -0.25 Q4 '19: -0.25 Q1 '20: -0.25 Q2 '20: -0.25 Q3 '20: -0.27 Q4 '20: -0.26 Q1 '21: -0.37 Q2 '21: -0.47 Q3 '21: -0.56 Q4 '21: -0.62 Q1 '22: -0.58 Q2 '22: -0.52 Q3 '22: -0.35 Q4 '22: -0.36 Q1 '23: -0.40 Q2 '23: -0.43 Q3 '23: -0.54 Q4 '23: -0.50 Q1 '24: -0.41 Q2 '24: -0.38 Q3 '24: -0.37 Q4 '24: -2.84 Q1 '25: -3.40 Q2 '26: -1.62 Q3 '26: -1.58 Q2 '13 Q1 '15 Q4 '16 Q3 '18 Q2 '20 Q1 '22 Q4 '23 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.